Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Comparison of FLU-BU12 Conditioning with the Standard BU-CY Myeloablative Regimen in High-Risk Pediatric ACUTE Myeloid Leukemia Patients Undergoing Allogeneic STEM Cell Transplantation

Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Polina Valerievna Kozhokar, Dr., Anastasia S Frolova, Dr, Liubov A. Tsvetkova, tsvetluibov@mail.ru, Kirill Alexandrovich Ekushov, Dr., Inna Markova, Sergey N. Bondarenko, Elena V. Babenko, Aleksandr L. Alyanskiy, aalyanskiygmail.com, Ildar M Barkhatov, MD PhD, Elena Vladimirovna Semenova, PhD, Aleksandr D. Kulagin, MD PhD, Ivan S. Moiseev, Ludmila S Zubarovskaya, MD PhD professor

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-139169

Published: 2020

Journal Articles

The Outcome of Patients with Advanced Phase Chronic Myeloid Leukemia with and without Allogeneic Hemopoietic Stem Cell Transplantation

Elena V. Morozova, Julia J. Vlasova, Maria V. Barabanshikova, Axel R. Zander, Ksenia Jurovskaya, Tatyana L. Gindina, Ildar Barhatov, Sergey N. Bondarenko, Ivan S. Moiseev, Ludmila S Zubarovskaya, MD PhD professor, Aleksandr D. Kulagin, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-139452

Published: 2020

Journal Articles

Factors Affecting Post-Transplant Relapse of Acute Lymphoblastic Leukemia (ALL) in Children According on the Intensity of Conditioning

Elena Vladimirovna Semenova, PhD, Polina Valerievna Kozhokar, Dr., Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Anastasia S Frolova, Dr, Luibov Tsvetkova, Kirill Alexandrovich Ekushov, Dr., Tatiana A Bykova, MD PhD, Anna A. Osipova, Inna Markova, Sergey N. Bondarenko, Boris I Smirnov, Ildar M Barkhatov, MD PhD, Tatyana L. Gindina, Ivan S. Moiseev, Axel R. Zander, Ludmila S Zubarovskaya, MD PhD professor

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-139466

Published: 2020

Journal Articles

Predictive Model of Response to Blinatumomab Therapy in Children and Adults with Relapsed/Refractory B-ALL

Inna Markova, Sergey N. Bondarenko, Olesia V Paina, PhD, Anna A. Osipova, Bella I Ayubova, Eugene A. Bakin, Anna G. Smirnova, Elena Babenko, Elena Vladimirovna Semenova, PhD, Ivan S. Moiseev, Axel R. Zander, Ludmila S Zubarovskaya, MD PhD professor

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-140242

Published: 2020

Journal Articles

Risk Factors for Overall Survival in Children with High Risk Acute Myeloid Leukemia (HR AML) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity of Conditioning Regimens

Elena Vladimirovna Semenova, PhD, Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Polina Valerievna Kozhokar, Dr., Anastasia S Frolova, Dr, Kirill Alexandrovich Ekushov, Dr., Tatiana A Bykova, MD PhD, Anna A. Osipova, Inna Markova, Sergey N. Bondarenko, Boris I Smirnov, Ildar M Barkhatov, MD PhD, Aleksandr Alyanski, Elena V. Babenko, Ivan S. Moiseev, Axel R. Zander, Ludmila S Zubarovskaya, MD PhD professor

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-137652

Published: 2020

Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT

Bhagirathbhai Dholaria, MBBS, Myriam Labopin, MD, Jaime Sanz Caballer, MD PhD, Annalisa Ruggeri, MD, Jan J. Cornelissen, MD PhD, Hélène Labussière-Wallet, Didier Blaise, MD, Edouard Forcade, MD, Patrice Chevallier, MD PhD, Anna Grassi, MD, Ludmila S Zubarovskaya, MD PhD professor, Jurgen H.E. Kuball, MD PhD, Patrice Ceballos, MD PhD, Fabio Ciceri, MD, Bipin N. Savani, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-139362

Published: 2020

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity Conditioning Regimens in Children with Very High Risk Acute Lymphoblastic Leukemia (VHR ALL): A Single-Center Experience

Elena Vladimirovna Semenova, MD PhD, Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Polina Valerievna Kozhokar, Dr., Anastasia S Frolova, Dr, Kirill Alexandrovich Ekushov, Dr., Tatiana A Bykova, MD PhD, Anna Osipova, Inna V Markova, Dr., Sergey N. Bondarenko, PhDMD, Ildar Barhatov, Aleksandr Alyanski, Elena Babenko, Ivan S Moiseev, MD PhD, Ludmila S Zubarovskaya, MD PhD professor, Axel Zander, Boris V Afanasyev, MD PhD professor

Blood (2019) 134 (Supplement_1): 2050.

https://doi.org/10.1182/blood-2019-128163

Published: 2019

Journal Articles

Invasive Fungal Diseases Caused By Rare Pathogens in Large Cohort of Pediatric and Adult Patients after Hematopoietic Stem Cell Transplantation and Chemotherapy

Blood (2019) 134 (Supplement_1): 4497.

https://doi.org/10.1182/blood-2019-127961

Published: 2019

Journal Articles

Comparison of Allogeneic Transplant Outcomes Using Conditioning with Different Dose of Busulfan for Children with Acute Myeloid Leukemia

Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Polina Valerievna Kozhokar, Dr., Anastasia S Frolova, Dr, Kirill Alexandrovich Ekushov, Dr., Luibov Tsvetkova, Tatiana A Bykova, MD PhD, Inna V Markova, Dr., Sergey N. Bondarenko, PhDMD, Ildar M Barkhatov, MD PhD, Aleksandr Alyanski, Elena Babenko, Ivan S Moiseev, MD PhD, Marina O Popova, MD PhD, Elena Vladimirovna Semenova, MD PhD, Ludmila S Zubarovskaya, MD PhD professor, Axel Zander, Boris Afanasyev

Blood (2019) 134 (Supplement_1): 4510.

https://doi.org/10.1182/blood-2019-128155

Published: 2019

Journal Articles

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Blood (2017) 130 (Supplement 1): 2604.

https://doi.org/10.1182/blood.V130.Suppl_1.2604.2604

Published: 2017

Journal Articles

Hematopoietic Stem Cell Transplantation for Children with Neurological Diseases Improves the Outcomes and Not Leads to Significant Late Effects — Report from Russian Group

Kirill Kirgizov, MD PhD, Anastasia Borovkova, MD, Elena Skorobogatova, MD PhD, Tatjana Bykova, MD PhD, Alexey A Maschan, MD PhD Professor, Ludmila S Zubarovskaya, MD PhD Professor, Axel R. Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor, Alexander Rumyantsev, MD PhD Professor

Blood (2017) 130 (Supplement 1): 4526.

https://doi.org/10.1182/blood.V130.Suppl_1.4526.4526

Published: 2017

Journal Articles

Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

Elena V Morozova, MDPhD, Ivan S Moiseev, MD PhD, Maria V Barabanshikova, MDPhD, Elena I Darskaya, MDPhD, Sergey N. Bondarenko, PhDMD, Ludmila S Zubarovskaya, MD PhD Professor, Vadim Baykov, Alexandr L Alyanski, Ildar M Barkhatov, MD PhD, Axel R. Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor

Blood (2017) 130 (Supplement 1): 4492.

https://doi.org/10.1182/blood.V130.Suppl_1.4492.4492

Published: 2017

NARROW

Comparison of FLU-BU12 Conditioning with the Standard BU-CY Myeloablative Regimen in High-Risk Pediatric ACUTE Myeloid Leukemia Patients Undergoing Allogeneic STEM Cell Transplantation

The Outcome of Patients with Advanced Phase Chronic Myeloid Leukemia with and without Allogeneic Hemopoietic Stem Cell Transplantation

Factors Affecting Post-Transplant Relapse of Acute Lymphoblastic Leukemia (ALL) in Children According on the Intensity of Conditioning

Predictive Model of Response to Blinatumomab Therapy in Children and Adults with Relapsed/Refractory B-ALL

Risk Factors for Overall Survival in Children with High Risk Acute Myeloid Leukemia (HR AML) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity of Conditioning Regimens

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT

Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity Conditioning Regimens in Children with Very High Risk Acute Lymphoblastic Leukemia (VHR ALL): A Single-Center Experience

Invasive Fungal Diseases Caused By Rare Pathogens in Large Cohort of Pediatric and Adult Patients after Hematopoietic Stem Cell Transplantation and Chemotherapy

Comparison of Allogeneic Transplant Outcomes Using Conditioning with Different Dose of Busulfan for Children with Acute Myeloid Leukemia

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Hematopoietic Stem Cell Transplantation for Children with Neurological Diseases Improves the Outcomes and Not Leads to Significant Late Effects — Report from Russian Group

Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only